02 November 2017
Moscow, November 2, 2017 – Yulia Sobakina, who used to head Department of private label brands in the pharmacy chain Rigla of the Protek Group of Companies, has been appointed as Commerce & Marketing Vice President of the pharmaceutical company NovaMedica.
“A professional with successful commercial experience in the Russian pharmaceutical market and excellent competences in marketing has joined our team. She managed a large product portfolio, brought to the market more than 30 pharmaceutical products in different categories and they gained significant market shares,” noted Alexander Kuzin, CEO of NovaMedica, “NovaMedica’s plans are ambitious, especially those connected with new partnerships and creation of own manufacturing facility, that is why new head of the commercial department will have a broader and more interesting area for both further development of opportunities of our company, and for professional growth.”
“I am glad to join NovaMedica’s team, one of the most dynamic in the pharmaceutical market. I am inspired by the possibility to use my professional experience and understanding of the market to promote product portfolio of NovaMedica. It is interesting from the point of combination of Gastro and Ophtha drugs from the leading world-class manufacturers and own drug products developed within the R&D program of NovaMedica. I hope that my knowledge and competences will help to find additional ways for the growth of the company share in the Russian pharmaceutical market”, commented Yulia Sobakina.
Yulia Sobakina has been working in the Russian pharmaceutical market for more than 20 years. Before joining NovaMedica she took the position of the Director of the Department of private label brands in the pharmacy chain Rigla within 4 years. There she managed implementation of the private label brands network Russia-wide, was responsible for the strategy of the company product portfolio development which she successfully implemented. Previously Yulia was Deputy Director for Commerce at the Pharmacy Chain 36.6, hold managing positions in the pharmacy chain Stary Lekar and the pharmaceutical distributor Moron.
Yulia graduated from the I.M. Sechenov Moscow Medical Academy, pharmaceutical faculty. Also she took training courses at the Moscow International Business School MIRBIS, MBA Marketing-management program.
NovaMedica is a modern Russian pharmaceutical company founded in 2012 by Domain Associates LLC, leading U.S. venture capital firm, and RUSNANO, JSC. NovaMedica possesses a well-developed infrastructure for promotion and sales of pharmaceutical products. Currently company is promoting a portfolio of 25 ophthalmological and gastroenterological products in the Russian market. NovaMedica's strategy is aimed at search, registration and localization in Russia of intellectual property rights for innovative pharmaceuticals products and technologies, as well as at development and implementation of own R&D projects. In April 2017 NovaMedica opened the Technological Center with state-of-the-art technological capabilities which were previously unavailable in the Russian pharmaceutical industry. NovaMedica became key partner of Pfizer in Russia in 2016. Within this partnership NovaMedica started construction of the pharmaceutical GMP manufacturing facility in the Kaluga region in May 2017.Print
18 February 2020
18 February 2020
17 February 2020
17 February 2020